Experimental protocols for behavioral imaging: Seeing animal models of drug abuse in a new light

Current Topics in Behavioral Neurosciences

Volumn 11, Issue , 2012, Pages 93-115

  Aarons, Alexandra R ^a,b   Talan, Amanda ^a   Schiffer, Wynne K ^a,c  

^a FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^b SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Addiction; Behavioral neuroimaging; Functional neuroimaging; Neuroimaging; Positron emission tomograph (PET); Resting state

Indexed keywords

FLUORODEOXYGLUCOSE F 18; RACLOPRIDE C 11; TRACER; DOPAMINE; RACLOPRIDE;

ANESTHESIA; ANIMAL BEHAVIOR; ANIMAL MODEL; ARTICLE; BRAIN FUNCTION; BRAIN METABOLISM; BRAIN REGION; CONDITIONED PLACE PREFERENCE TEST; DOPAMINERGIC TRANSMISSION; DRUG ABUSE; DRUG WITHDRAWAL; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; IMAGE ANALYSIS; NEUROIMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; ADDICTION; ANIMAL; BRAIN; DIAGNOSTIC USE; DISEASE MODEL; DRUG EFFECTS; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; SCINTISCANNING;

ANIMALS; BRAIN; DISEASE MODELS, ANIMAL; DOPAMINE; FLUORODEOXYGLUCOSE F18; HUMANS; NEUROIMAGING; RACLOPRIDE; SUBSTANCE-RELATED DISORDERS;

EID: 84890058390     PISSN: 18663370     EISSN: 18663389     Source Type: Book Series    
DOI: 10.1007/7854_2012_206     Document Type: Article

References (71)

1. Alavi A, Smith R, Duncan D (1994) What are the sources of error in measuring and calculating cerebral metabolic rates with fluorine-18-fluorodeoxyglucose and PET? J Nucl Med 35: 1466-1470
2. Alkire MT, Pomfrett CJ, Haier RJ, Gianzero MV, Chan CM, Jacobsen BP, Fallon JH (1999) Functional brain imaging during anesthesia in humans: effects of halothane on global and regional cerebral glucose metabolism. Anesthesiology 90: 701-709
3. Becerra L, Chang PC, Bishop J, Borsook D (2011) CNS activation maps in awake rats exposed to thermal stimuli to the dorsum of the hindpaw. Neuroimage 54: 1355-1366
4. Borsook D, Becerra L (2011) CNS animal fMRI in pain and analgesia. Neurosci Biobehav Rev 35: 1125-1143
5. Borsook D, Becerra L, Hargreaves R (2006) A role for fMRI in optimizing CNS drug development. Nat Rev Drug Discov 5: 411-424
6. Bressan RA, Erlandsson K, Mulligan RS, Gunn RN, Cunningham VJ, Owens J, Cullum ID, Ell PJ, Pilowsky LS (2004) A bolus/infusion paradigm for the novel NMDA receptor SPET tracer [123I]CNS 1261. Nucl Med Biol 31: 155-164
7. Brodie JD (1996) Imaging for the clinical psychiatrist: facts, fantasies, and other musings [editorial]. Am J Psychiatry 153: 145-149
8. Camargo EE, Szabo Z, Links JM, Sostre S, Dannals RF, Wagner HN, Jr. (1992) The influence of biological and technical factors on the variability of global and regional brain metabolism of 2-[18F]fluoro-2-deoxy-D-glucose. J Cereb Blood Flow Metab 12: 281-290
9. Cumming P, Caprioli D, Dalley JW (2011) What have positron emission tomography and 'Zippy' told us about the neuropharmacology of drug addiction? Br J Pharmacol 163: 1586-1604
10. Dalley JW, Fryer TD, Brichard L, Robinson ES, Theobald DE, Laane K, Pena Y, Murphy ER, Shah Y, Probst K, Abakumova I, Aigbirhio FI, Richards HK, Hong Y, Baron JC, Everitt BJ, Robbins TW (2007) Nucleus accumbens D2/3 receptors predict trait impulsivity and cocaine reinforcement. Science 315: 1267-1270
11. Dalley JW, Fryer TD, Aigbirhio FI, Brichard L, Richards HK, Hong YT, Baron JC, Everitt BJ, Robbins TW (2009) Modelling human drug abuse and addiction with dedicated small animal positron emission tomography. Neuropharmacology 56(Suppl 1): 9-17
12. Egerton A, Mehta MA, Montgomery AJ, Lappin JM, Howes OD, Reeves SJ, Cunningham VJ, Grasby PM (2009) The dopaminergic basis of human behaviors: a review of molecular imaging studies. Neurosci Biobehav Rev 33: 1109-1132
13. Erlandsson K, Bressan RA, Mulligan RS, Gunn RN, Cunningham VJ, Owens J, Wyper D, Ell PJ, Pilowsky LS (2003) Kinetic modelling of [123I]CNS 1261-a potential SPET tracer for the NMDA receptor. Nucl Med Biol 30: 441-454
14. Fischer K, Sossi V, Schmid A, Thunemann M, Maier FC, Judenhofer MS, Mannheim JG, Reischl G, Pichler BJ (2011) Noninvasive nuclear imaging enables the in vivo quantification of striatal dopamine receptor expression and raclopride affinity in mice. J Nucl Med 52: 1133-1141
15. Frumberg DB, Fernando MS, Lee DE, Biegon A, Schiffer WK (2007) Metabolic and behavioral deficits following a routine surgical procedure in rats. Brain Res 1144: 209-218
16. Grady CL, McIntosh AR, Beig S, Craik FI (2001) An examination of the effects of stimulus type, encoding task, and functional connectivity on the role of right prefrontal cortex in recognition memory. Neuroimage 14: 556-571
17. Gremese F, Schulz FW (2011) Qualitative and quantitative data analysis. In: Keiessling F, Pichler BJ (eds) Small animal imaging, Springer, Berlin, pp 363-378
18. Holschneider DP, Maarek JM (2004) Mapping brain function in freely moving subjects. Neurosci Biobehav Rev 28: 449-461
19. Holschneider DP, Maarek JM, Harimoto J, Yang J, Scremin OU (2002) An implantable bolus infusion pump for use in freely moving, nontethered rats. Am J Physiol Heart Circ Physiol 283: H1713-H1719
20. Holschneider DP, Maarek JM, Yang J, Harimoto J, Scremin OU (2003) Functional brain mapping in freely moving rats during treadmill walking. J Cereb Blood Flow Metab 23: 925-932
21. Horwitz B, Rowe JB (2011) Functional biomarkers for neurodegenerative disorders based on the network paradigm. Prog Neurobiol 95: 505-509
22. Houston GC, Hume SP, Hirani E, Goggi JL, Grasby PM (2004) Temporal characterisation of amphetamine-induced dopamine release assessed with [11C]raclopride in anaesthetised rodents. Synapse 51: 206-212
23. Huang SC, Wu HM, Shoghi-Jadid K, Stout DB, Chatziioannou A, Schelbert HR, Barrio JR (2004) Investigation of a new input function validation approach for dynamic mouse microPET studies. Mol Imaging Biol 6: 34-46
24. Huang C, Tang C, Feigin A, Lesser M, Ma Y, Pourfar M, Dhawan V, Eidelberg D (2007) Changes in network activity with the progression of Parkinson's disease. Brain 130: 1834-1846
25. Hume SP, Opacka-Juffry J, Myers R, Ahier RG, Ashworth S, Brooks DJ, Lammertsma AA (1995) Effect of L-dopa and 6-hydroxydopamine lesioning on [11C]raclopride binding in rat striatum, quantified using PET. Synapse 21: 45-53
26. Hyder F, Rothman DL (2011) Evidence for the importance of measuring total brain activity in neuroimaging. Proc Natl Acad Sci U S A 108: 5475-5476
27. Kalisch R, Elbel GK, Gossl C, Czisch M, Auer DP (2001) Blood pressure changes induced by arterial blood withdrawal influence bold signal in anesthesized rats at 7 Tesla: implications for pharmacologic MRI. Neuroimage 14: 891-898
28. Katz JL, Higgins ST (2003) The validity of the reinstatement model of craving and relapse to drug use. Psychopharmacology (Berl) 168: 21-30
29. Khubchandani M, Mallick HN, Jagannathan NR, Mohan Kumar V (2003) Stereotaxic assembly and procedures for simultaneous electrophysiological and MRI study of conscious rat. Magn Reson Med 49: 962-967
30. Kornblum HI, Araujo DM, Annala AJ, Tatsukawa KJ, Phelps ME, Cherry SR (2000) In vivo imaging of neuronal activation and plasticity in the rat brain by high resolution positron emission tomography (microPET). Nat Biotechnol 18: 655-660
31. Kung MP, Kung HF (2005) Mass effect of injected dose in small rodent imaging by SPECT and PET. Nucl Med Biol 32: 673-678
32. Lancelot S, Zimmer L (2010) Small-animal positron emission tomography as a tool for neuropharmacology. Trends Pharmacol Sci 31: 411-417
33. Langford DJ, Crager SE, Shehzad Z, Smith SB, Sotocinal SG, Levenstadt JS, Chanda ML, Levitin DJ, Mogil JS (2006) Social modulation of pain as evidence for empathy in mice. Science 312: 1967-1970
34. Langford DJ, Tuttle AH, Brown K, Deschenes S, Fischer DB, Mutso A, Root KC, Sotocinal SG, Stern MA, Mogil JS, Sternberg WF (2010) Social approach to pain in laboratory mice. Social neuroscience 5: 163-170
35. Laruelle M, Iyer RN, al-Tikriti MS, Zea-Ponce Y, Malison R, Zoghbi SS, Baldwin RM, Kung HF, Charney DS, Hoffer PB, Innis RB, Bradberry CW (1997) Microdialysis and SPECT measurements of amphetamine-induced dopamine release in nonhuman primates. Synapse 25: 1-14
36. Li A, Gong L, Xu F (2011) Brain-state-independent neural representation of peripheral stimulation in rat olfactory bulb. Proc Natl Acad Sci U S A 108: 5087-5092
37. Magota K, Kubo N, Kuge Y, Nishijima K, Zhao S, Tamaki N (2011) Performance characterization of the Inveon preclinical small-animal PET/SPECT/CT system for multimodality imaging. Eur J Nucl Med Mol Imaging 38: 742-752
38. Marsteller DA, Barbarich-Marsteller NC, Fowler JS, Schiffer WK, Alexoff DL, Rubins DJ, Dewey SL (2006) Reproducibility of intraperitoneal 2-deoxy-2-[(18)F]-fluoro-D-glucose cerebral uptake in rodents through time. Nucl Med Biol 33: 71-79
39. Matsumura A, Mizokawa S, Tanaka M, Wada Y, Nozaki S, Nakamura F, Shiomi S, Ochi H, Watanabe Y (2003) Assessment of microPET performance in analyzing the rat brain under different types of anesthesia: comparison between quantitative data obtained with microPET and ex vivo autoradiography. Neuroimage 20: 2040-2050
40. McArthur R (2011) Many are called, yet few are chosen. Are neuropsychiatric clinical trials letting us down? Drug Discov Today 16: 173-175
41. Meyer PT, Circiumaru V, Cardi CA, Thomas DH, Bal H, Acton PD (2006) Simplified quantification of small animal [18F]FDG PET studies using a standard arterial input function. Eur J Nucl Med Mol Imaging 33: 948-954
42. Mirrione MM, Schiffer WK, Siddiq M, Dewey SL, Tsirka SE (2006) PET imaging of glucose metabolism in a mouse model of temporal lobe epilepsy. Synapse 59: 119-121
43. Mirrione MM, Schiffer WK, Fowler JS, Alexoff DL, Dewey SL, Tsirka SE (2007) A novel approach for imaging brain-behavior relationships in mice reveals unexpected metabolic patterns during seizures in the absence of tissue plasminogen activator. Neuroimage 38: 34-42
44. Morcom AM, Fletcher PC (2007) Does the brain have a baseline? Why we should be resisting a rest. Neuroimage 37: 1073-1082
45. Patel VD, Lee DE, Alexoff DL, Dewey SL, Schiffer WK (2008) Imaging dopamine release with positron emission tomography (PET) and (11)C-raclopride in freely moving animals. Neuroimage 41: 1051-1066
46. Phelps ME, Huang SC, Hoffman EJ, Selin C, Sokoloff L, Kuhl DE (1979a) Tomographic measurement of local cerebral glucose metabolic rate in humans with [18F]2-fluoro-2-deoxyglucose: validation of method. Ann Neurol 6: 371-388
47. Phelps ME, Huang SC, Hoffman EJ, Selin C, Sokoloff L, Kuhl DE (1979b) Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: validation of method. Ann Neurol 6: 371-388
48. Ravasi L, Shimoji K, Soto-Montenegro ML, Esaki T, Seidel J, Sokoloff L, Schmidt K (2011) Use of [18F]fluorodeoxyglucose and the ATLAS small animal PET scanner to examine cerebral functional activation by whisker stimulation in unanesthetized rats. Nucl Med Commun 32: 336-342
49. Schiffer WK, Gerasimov MR, Bermel RA, Brodie JD, Dewey SL (2000) Stereoselective inhibition of dopaminergic activity by gamma vinyl-GABA following a nicotine or cocaine challenge: a PET/microdialysis study. Life Sci 66: PL169-PL173
50. Schiffer WK, Alexoff DL, Shea C, Logan J, Dewey SL (2005) Development of a simultaneous PET/microdialysis method to identify the optimal dose of 11C-raclopride for small animal imaging. J Neurosci Meth 144: 25-34
51. Schiffer WK, Mirrione MM, Biegon A, Alexoff DL, Patel V, Dewey SL (2006) Serial microPET measures of themetabolic reaction to amicrodialysis probe implant. JNeurosciMeth 155: 272-284
52. Schiffer WK, Mirrione MM, Dewey SL (2007) Optimizing experimental protocols for quantitative behavioral imaging with 18F-FDG in rodents. J Nucl Med 48: 277-287
53. Schiffer WK, Liebling CN, Reiszel C, Brodie JD, Dewey SL (2009) Cue-induced dopamine release predicts cocaine preference: PET studies in freely moving rodents. J Neurosci 29(19): 6176-6185(in press)
54. Schulz D, Vaska P (2011) Integrating PET with behavioral neuroscience using RatCAP tomography. Rev Neurosci 22: 647-655
55. Shaham Y, Shalev U, Lu L, De Wit H, Stewart J (2003) The reinstatement model of drug relapse: history, methodology and major findings. Psychopharmacology (Berl) 168: 3-20
56. Shimoji K, Ravasi L, Schmidt K, Soto-Montenegro ML, Esaki T, Seidel J, Jagoda E, Sokoloff L, Green MV, Eckelman WC (2004) Measurement of cerebral glucose metabolic rates in the anesthetized rat by dynamic scanning with 18F-FDG, the ATLAS small animal PET scanner, and arterial blood sampling. J Nucl Med 45: 665-672
57. Shulman RG, Hyder F, Rothman DL (2003) Cerebral metabolism and consciousness. C R Biol 326: 253-273
58. Sokoloff L, Reivich M, Kennedy C, Des Rosiers MH, Patlak CS, Pettigrew KD, Sakurada O, Shinohara M (1977) The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J Neurochem 28: 897-916
59. Steward CA, Marsden CA, Prior MJ, Morris PG, Shah YB (2005) Methodological considerations in rat brain BOLD contrast pharmacological MRI. Psychopharmacology 180: 687-704
60. Toyama H, Ichise M, Liow JS, Vines DC, Seneca NM, Modell KJ, Seidel J, Green MV, Innis RB (2004a) Evaluation of anesthesia effects on [18F]FDG uptake in mouse brain and heart using small animal PET. Nucl Med Biol 31: 251-256
61. Toyama H, Ichise M, Liow JS, Modell KJ, Vines DC, Esaki T, Cook M, Seidel J, Sokoloff L, Green MV, Innis RB (2004b) Absolute quantification of regional cerebral glucose utilization in mice by 18F-FDG small animal PET scanning and 2-14C-DG autoradiography. J Nucl Med 45: 1398-1405
62. Ulug AM, Vo A, Argyelan M, Tanabe L, Schiffer WK, Dewey S, Dauer WT, Eidelberg D (2011) Cerebellothalamocortical pathway abnormalities in torsinA DYT1 knock-in mice. Proc Natl Acad Sci U S A 108: 6638-6643
63. Vincent JL, Patel GH, Fox MD, Snyder AZ, Baker JT, Van Essen DC, Zempel JM, Snyder LH, Corbetta M, Raichle ME (2007) Intrinsic functional architecture in the anaesthetized monkey brain. Nature 447: 83-86
64. Volkow ND, Wang GJ, Telang F, Fowler JS, Logan J, Childress AR, Jayne M, Ma Y, Wong C (2006) Cocaine cues and dopamine in dorsal striatum: mechanism of craving in cocaine addiction. J Neurosci 26: 6583-6588
65. Volkow ND, Wang GJ, Telang F, Fowler JS, Logan J, Childress AR, Jayne M, Ma Y, Wong C (2008) Dopamine increases in striatum do not elicit craving in cocaine abusers unless they are coupled with cocaine cues. Neuroimage 39: 1266-1273
66. Wadenberg ML, Kapur S, Soliman A, Jones C, Vaccarino F (2000) Dopamine D2 receptor occupancy predicts catalepsy and the suppression of conditioned avoidance response behavior in rats. Psychopharmacology (Berl) 150: 422-429
67. Wadenberg ML, Soliman A, VanderSpek SC, Kapur S (2001) Dopamine D2 receptor occupancy is a common mechanism underlying animal models of antipsychotics and their clinical effects. Neuropsychopharmacology 25: 633-641
68. Wilkinson LS, Humby T, Killcross AS, Torres EM, Everitt BJ, Robbins TW (1998) Dissociations in dopamine release in medial prefrontal cortex and ventral striatum during the acquisition and extinction of classical aversive conditioning in the rat. Eur J Neurosci 10: 1019-1026
69. Wong DF et al (2006) Increased occupancy of dopamine receptors in human striatum during cueelicited cocaine craving. Neuropsychopharm 31: 2716-2727
70. Wong KP, Sha W, Zhang X, Huang SC (2011) Effects of administration route, dietary condition, and blood glucose level on kinetics and uptake of 18F-FDG in mice. J Nucl Med 52: 800-807
71. Yoder KK, Mock BH, Zheng QH, McCarthy BP, Riley AA, Hutchins GD (2011) Assessment of i. p. injection of [18F]fallypride for behavioral neuroimaging in rats. J Neurosci Methods 196: 70-75